Preliminary study in diagnosis and early prediction of preeclampsia by using FTIR spectroscopy technique

Life Science Journal

Volumn 8, Issue 2, 2011, Pages 453-464

  Raouf, Gehan A ^a   Al Malki, Abdel Rahman L ^a   Mansouri, Nesma ^b   Mahmoudi, Rogaia M ^a  

^a KING ABDULAZIZ UNIVERSITY   (Saudi Arabia)

^b Aziz University   (Saudi Arabia)

Author keywords

Dyslipidemia; Fourier Transform Infrared Spectroscopy (FTIR); Oxidative Stress; Preeclampsia; Serum

Indexed keywords

EID: 79957750882     PISSN: 10978135     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (57)

1. Carl A, Oxidative stress in the Pathogenesis of preeclampsia. 1999; 222-235
2. Francois A, Screening for pre-eclampsia: the quest for the holy grail? The Lancet 2005; 365(9468): 1367-1369.
3. Villar J, Say L, Shennan A, Lindheimer M, Duley L, Conde-Agudelo A, Merialdi M, Methodological and technical issues related to the diagnosis, screening, prevention, and treatment of preeclampsia and eclampsia. Int. J. Gynecol. Obstet. 85 Suppl.1 2004; S28-S41.
4. nd ed.) Stamford, CT: Appleton & Lange, pp395-429, 1999.
5. Roberts J, Endothelial dysfunction in preeclampsia. Sem Report Endocrinol. 1998;16: 5-15.
6. Krauss T, Juhn W, Lakoma C, Augustin HG, Circulating endothelial cell adhesion molecules as diagnostic markers for the early identification of pregnant women at risk for development of preeclampsia. Am. J. Obstet. Gynecol. 1997; 177: 443-449.
7. Taylor RN, Crombleholme WR, Friedman SA, Jones LA., Casal DC, Roberts JM, High plasma cellular fibronectin levels correlate with biochemical and clinical features of preeclampsia but cannot be attributed to hypertension alone. Am. J. Obstet. Gynecol. 1991; 165: 895-901.
8. Stark J, Preeclampsia and cytokine induced oxidative stress. Br. J. Obstet. Gynecol. 1993; 100: 105-9.
9. Carmona P, Rodriguez-Casado A, Alvarez I, de Miguel E, Toledano A, FTIR microspectroscopic analysis of the effect of certain drugs on oxidative stress and brain structure. Biopolymer 2008;89:548-554.
10. Dumas P and Miller J, The use of synchrotron infrared microspectroscopy in biological and biomedical investigations. Vib. Spec. 2003;32:3-21.
11. Griffiths PR, and de Haseth JA, Fourier transform infrared spectrometry. John Wiley and Sons, New York, 45, 1986.
12. Jakson M and Mantsch HH, In Mantsch H.H., Chapman D. (eds.), Infrared spectroscopy of biomolecules, Wiley-Liss, Toronto, 311, 1996.
13. Baker MJ, Gazi E, Brown MD, Shanks JH, Gardner P, and Clarke NW, FTIR-based spectroscopic analysis in the identification of clinically aggressive prostate cancer. British J. Cancer 2008; 99: 1859-1866.
14. Paul GL, Robert DS, Cancer grading by Fourier transform infrared spectroscopy. 1998;4: 37-46.
15. Jackson M, Sowa MG, Mantsch HH, Infrared spectroscopy: a new frontier in medicine. Biophys. Chem. 1997; 68: 109-125.
16. Diem M, Boydston-White S, & Chiriboga L, Infrared spectroscopy of cells and tissues: shining light on a noval subject. Appl. Spectrosc. 1999; 53: 148A-161A.
17. Cuningham FG, Gant NF, Leveno KJ, Gilstrap III LC, Hauth JC, Wenstrom KD, Williams Obstetrics. 21 st Ed. McGraw-Hill 2001; 568-9.
18. Wong PT, Wong RK, Caputo TA, Godwin TA, Rigas B, Infrared spectroscopy of exfoliated human cervical cells: evidence of extensive structural changes during carcinogenesis. Proc. Natl. Acad. Sci. USA 88, 10988-10992 (1991).
19. Liu K-Z, Li Jia, Kelsey SM, Newland AC, Mantsch HH, Quantitative determination of apoptosis on leukemia cells by infrared spectroscopy. Apoptosis 2001;6: 269-278.
20. Mantsh HH, Apoptosis-induced structural changes in leukemia cells identified by IR spectroscopy J. Mol. Str. 2001; 565-566: 299-304.
21. Deleris G, Petibios C, Application of FT-IR spectrometry to plasma contents analysis and monitoring. Vib. Spectrosc. 2003; 32: 129.
22. Cakmak G, Togan I, & Severcan F. 17â-Estradiol induced compositional, structural and functional changes in rainbow trout liver, revealed by FT-IR spectroscopy: A comparative study with nonylphenol. Aquatic Toxicology 2006; 77:53-63.
23. Jackson M, Ramjiawan B, Hewko M, Mantsch H, Infrared microscopic functional group mapping and spectral clustering analysis of hypercholestereolemic rabbit liver, Cell. Mol. Biol. 1998;44: 89-98.
24. Toyran N, Lasch P, Naumann D, Turan B, & Severcan F. Early alterations in mycocardia and vessels of the diabetic rat heart: An FTIR spectroscopic study. Biochem. J. 2006; 397:427-436.
25. Toyran N, Zorlu F, Donmez G, Oge K, & Severcan F. Chronic hypoperfusion alters the content and structure of proteins and lipids of rat brain homogenates: A Fourier transform infrared spectroscopy study. Eur. Biophys. J. Biophys. Let. 2004; 33: 549-554.
26. Garidel P. Mid-FTIR-microspectroscopy of stratum corneum single cells and stratum corneum tissue. Physic. Chem. Chem. Phys. 2002; 4:5671-5677.
27. Hendler RW, Barnett SM, Dracheva S, Bose S, & Levin IW. Purple membrane lipid control of bacteriorhodopsin conformational flexibility and photocycle activity-An infrared spectroscopic study. Eur. J. Biochem. 2003; 270:1920-1925.
28. Mendelsohn R, & Mantsch HH. Fourier transform infrared studies of lipid-protein interaction. In A. Watts & J.J. H. H. M. De Pont)Eds). Progress in protein-lipid interactions (vol. 2. pp. 103-147). Amsterdam: Elsevier Science Publishers.
29. Conde-Agudelo, Agustin MD, MPH; Villar, Jase MD, MPH, Lindheimer, Mushal MD. World Health Organization Systematic Review of Screening Tests for Preeclampsia. Obstet. Gynecol. 2004; 104(6): 1367-1391.
30. Sinclair A, Barnett A, Lunec J, Free radicals and antioxidant systems in health and disease. Br. J. Hosp. Med. 1990; 43: 334-344.
31. Corinne M, John R, Ewen W, Rhoda W, James J, James Mc, Erythrocyte glutathione balance and membrane stability during preeclampsia. Free Radical Biol. Med. (1998); 24(6): 1049-1055.
32. Smith WL, Marnett LJ, DeWitt DL, Prostaglandin and thromboxane biosynthesis. Pharmacol Ther. 1991; 49: 153-179.
33. Sen CK, Packer L, Antioxidant and redox regulation of gene transcription. FASEB J 1996;10: 709-720.
34. Hubel CA, Roberts JM, Taylor RN, Musci TJ, Rogers GM, McLaughlin MK, Lipid peroxidation in pregnancy: New perspectives on preeclampsia. Am. J. Obstet. Gynecol. 1989; 161:1025-1034.
35. Walsh SW, Maternal-placental interactions of oxidative stress and antioxidants in preeclampsia. Sem Reprod Endocrinol. 1998; 16: 93-104.
36. Goldwasser P, Feldman J, Association of serum albumin and mortality risk, J. Clin. Epidemiol. 1997; 50: 693-703.
37. Philips A, Shaper A, Whincup P, Serum proteins and mortality, Lancet 1990; 335: 858.
38. Halliwell B, How to characterize a biological antioxidant, Free Radic. Res. Commun. 1990; 9: 1-32.
39. Soriani M, Pietraforte D, Minetti M, Antioxidant potential of anaerobic human plasma: role of serum albumin and thiols as scavengers of carbon radicals, Arch. Biochem. Biophys. 1994;312: 180-188.
40. Terawaki H, Yoshimura K, Hasegawa T, Matsuyama Y, Negawa T, Yamada K, Matsushima M et al, Oxidative stress is enhanced in correlation with renal dysfunction: examination with the redox state of albumin, Kidney Int. 2004;66: 1988-1993.
41. Fraile M, Blanco-Melgar, Martinez R, Lopse G, Gallego J, Carmona P, Structure and interactions of albumin-Lipid Systems as studied by infrared spectroscopy. J. M, Strac. 2003; 651-653: 231-236.
42. Serge C, Philippe R, Sergio A, Emmanuel B, Effect of Oxidative modifications induced by the glycation of bovine serum albumin on its structure and on cultured adipose cells. Biochimie. 2006; 88(10): 1467-1477.
43. Cohen M, Elizabeth S, Sheldon C, Clyde W, Glycated albumin increases oxidative stress, activates NF-kB and extracellular regulated kinase (ERK), and stimulates ERK-dependent transforming growth factor-â1 production in macrophage RAW cells. J. Lab. Clin. Med. 2003; 141(4): 242.
44. Catalano PM, et al. Longitudinal changes in glucose metabolism during pregnancy in obese women with normal glucose tolerance and gestational diabetes mellitus. AM J Obstet Gynecol. 1999;180: 903-16.
45. Kuhl C, Etiology and pathogenesis of gestational diabetes. Diabetes Care 1998; 21(Suppl 2): B19-26.
46. Payor WA, Godber SS, Noninvasive measure of oxidative stress status in humans. Free Radic. Biol. Med. 1991; 10: 177-184.
47. Puhl H, Waeg G., Esterbauer H, Methods to determine oxidation of low-density lipoproteins In: Packer L, Ed. Methods in Enzymology. San Diego: Academic Press, pp425-441, 1994.
48. Morris JM, Gopaul NK, Endresen MJ, Knight M, Linton EA, Dhir S, Anggard EE, Redman CW, Circulating markers of oxidative stress are raised in normal pregnancy and preeclampsia. Br. J. Obstet. Gynaecol. 1998; 105:1195-1199.
49. Arthur M, Richard L, Kevin L, Sina H, and Boggess K, Maternal serum dyslipidemia occurs early in pregnancy in women with mild but not severe preeclampsia. Am. J. Obstet. Gynecol. 2009; 201:293.
50. Sattar N, Bendomir A, Berry C, Shepherd J, Greer IA, Packard C, Lipoprotein subfraction concentrations in preeclampsia: pathogenic parallels to atherosclerosis. Obstet. Gynecol. 1997; 89: 403-8.
51. Lorentzen B, Endresen M, Clausen T, Henriksen T, Fasting serum free fatty acids and triglycerides are increased before 20 weeks of gestation in women who later develop preeclampsia. Hypertens Pregnancy 1994; 13: 103-9.
52. Chappell L, Seed P, Briley A, et al., A longitudinal study of biochemical variables in women at risk of preeclampsia. Am. J. Obstet. Gynecol. 2002; 187:127-36.
53. Gratacos E, Casals E, Sanllehy C, Cararach V, Alonso P, Fortuny A, Variation in lipid levels during pregnancy in women with different types of hypertension. Acta Obstet. Gynecol. Scand. 1996; 75: 896-901.
54. Carmena R, Duriez P, Fruchart J, Atherogenic lipoprotein particles in atherosclerosis. Circulation 109 (suppl 1) 1112-1117. View Record in Scopus Cited By in Scopus (87).
55. Rubina A, Tabassum M, Pre-eclampsia and lipid profile. Pak J. Med Sci. 2007; 23(5): 751-754.
56. Masayuki N, Mitsuyo O, Hiroyuki K, Infrared study of human serum very low-density and lowdensity lipoptoteines. Implication of esterified lipid C=O stretching bands for characterizing lipoproteins. Chem. Phys. Lipids 2002; 117(1-2): 1-6.
57. Henry SL, Andrew P, John N, Manford D, Grady W, Quantitative determination of low density lipoprotein oxidation by FTIR and chemometric analysis. Lipids 2004; 39(7): 687.